1Cell.Ai
PrivateLast Round
Series A
Nov 21, 2024
Total Funding Raised
$16.08M
Company Overview
1Cell.Ai is a biotechnology company that provides an AI-powered precision oncology platform designed to accelerate the discovery of rare cell populations and improve cancer diagnostics and treatment.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical AI, Biotechnology, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
1Cell.Ai Comps
Public and private peers based on sector, stage, and business model.
1Cell.Ai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 21, 2024 | ||||
| Grant | Jul 11, 2021 |
Key People
Founding team and executive leadership
1Cell.Ai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotechnology Industry Research Assistance Council | Grant |
| WRVI Capital | Series A |
| Eragon Ventures | Series A |
| Singularity Growth | Series A |
| Department of Biotechnology | Grant |
| Tenacity Ventures | Series A |
1Cell.Ai Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 1Cell.Ai's valuation, stock price, and market status.